MYC and acute myeloid leukemia: METTL14 upregulation mediated by oncogenic protein SPI1 catalyzes m6A reaction on target mRNA MYB and MYC, attenuating HSPCs myeloid differentiation and enhancing self-renewal of leukemia stem/initiation cells (LSC/LICs), ultimately accelerating AML development 115.